La reunion health survey aims to uncover hidden disease patterns

NCT ID NCT05400824

Recruiting now Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study measures how common heart disease, diabetes, obesity, and infections like dengue and COVID-19 are among adults in La Reunion. Researchers will also look at possible risk factors, including gut bacteria, genetics, and social conditions. Participants provide blood, DNA, and other samples, and undergo tests like heart ultrasound and lung function. The goal is to better understand the health challenges facing the island's population.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal why certain diseases are more common in La Reunion and point to new prevention strategies.
What could go wrong: This is an observational study, not a treatment trial. It can identify links but cannot prove what causes disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Cognitive Dysfunction dengue disease Dyslipidemias hypertensive disorder infectious disease metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES GENERAL POPULATION INFECTIOUS DISEASE METABOLIC DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre Hospitalier Universitaire de La Réunion
RECRUITING

La Réunion, Saint-Pierre, 97448, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.